Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma

Chemoresistance, especially temozolomide (TMZ) resistance, is a major clinical challenge in the treatment of glioblastoma (GBM). Exploring the mechanisms of TMZ resistance could help us identify effective therapies. Adenosine deaminases acting on RNA (ADARs) are very important in RNA modification th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Can, Chen, Xi, Yan, Yuanliang, Ren, Xinxin, Wang, Xiang, Peng, Bi, Cai, Yuan, Liang, Qiuju, Xu, Zhijie, Peng, Jinwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844449/
https://www.ncbi.nlm.nih.gov/pubmed/35177985
http://dx.doi.org/10.3389/fphar.2022.768743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844449/
https://www.ncbi.nlm.nih.gov/pubmed/35177985
http://dx.doi.org/10.3389/fphar.2022.768743

Ejemplares similares